Alexander KarpAlexander Karp earned $1B in 2024

1+ years at the helm of Poseida Therapeutics, Inc..

Compensation History

Annual executive compensation data for Kristin Yarema, Ph.D., including salary, bonuses, and stock awards.

No compensation data available for Kristin Yarema, Ph.D. yet. Come back soon!

P

Kristin Yarema, Ph.D.

CEO of Poseida Therapeutics, Inc.

Education

Ph.D. in Molecular Biology from Stanford University

Sector of Economy

Healthcare

Born

January 1, 1978 - 47 years ago

CEO of Poseida Therapeutics, Inc. for

1 year 11 months (Jan 2024 - Present)

Previous Experience

President of Cell Therapy at Poseida Therapeutics, Inc.

Holdings

Track Kristin Yarema, Ph.D.'s stock holdings and portfolio value over time.

Insider Trading

Kristin Yarema, Ph.D.'s recent stock transactions, purchases, and sales filed with the SEC.

No insider trades found for this CEO.

Rivals

Compare Kristin Yarema, Ph.D. with competitor CEOs and industry peers.